TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
TCRR
Delisted
TCRR was delisted on the 31st of May, 2023.
58 hedge funds and large institutions have $31.4M invested in TCR2 Therapeutics Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 17 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
Holders
58
Holding in Top 10
1
Calls
$30K
Puts
–
Top Buyers
| 1 | +$890K | |
| 2 | +$763K | |
| 3 | +$147K | |
| 4 |
SC
Sagefield Capital
Dallas,
Texas
|
+$59.1K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$50.4K |
Top Sellers
| 1 | -$335K | |
| 2 | -$234K | |
| 3 | -$200K | |
| 4 |
Two Sigma Advisers
New York
|
-$187K |
| 5 |
Millennium Management
New York
|
-$146K |
